First-line (1L) immuno-oncology (10) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

被引：2

作者：

Dudani, Shaan

Graham, Jeffrey

Wells, Connor

Pal, Sumanta K.

Dizman, Nazli

Donskov, Frede

Bjarnason, Georg A.

Hansen, Aaron Richard

Iafolla, Marco Adelmo James

Vaishampayan, Ulka N.

Porta, Camillo

Beuselinck, Benoit

Yan, Flora

Wood, Lori

Liow, Elizabeth Chien Hern

Kollmannsberger, Christian K.

Yuasa, Takeshi

Zhang, Chiyuan A.

Choueiri, Toni K.

Heng, Daniel Yick Chin

机构：

[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada

[2] Univ Manitoba, Winnipeg, MB, Canada

[3] City Hope Natl Med Ctr, Duarte, CA USA

[4] City Hope Comprehens Canc Ctr, Duarte, CA USA

[5] Aarhus Univ Hosp, Aarhus, Denmark

[6] Sunnybrook Res Inst, Toronto, ON, Canada

[7] Princess Margaret Canc Ctr, Toronto, ON, Canada

[8] Univ Alberta, Edmonton, AB, Canada

[9] Karmanos Canc Inst, Detroit, MI USA

[10] Univ Pavia, Pavia, Italy

[11] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium

[12] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[13] Dalhousie Univ, Halifax, NS, Canada

[14] Eastern Hlth, Melbourne, Vic, Australia

[15] Univ British Columbia, Vancouver, BC, Canada

[16] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

[17] Stanford Hosp, Stanford, CA USA

[18] Dana Farber Canc Inst, Boston, MA 02115 USA

[19] Univ Calgary, Calgary, AB, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期

关键词：

D O I：

10.1200/JCO.2019.37.7_suppl.584

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

584

引用

页数：2